PHARMACOLOGICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2020-12-12 ms1000001706153386

审稿速度:1.0 | 投稿命中率:50.0
经验分享：一审15天，一周修回，2小时后accept，效率奇高

391 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2020-12-02 泪湿青衣

审稿速度:1.0 | 投稿命中率:75.0
经验分享：一审20天，给了一个月修回，修回后第二天立马接收了

360 33

展开33条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

6小时前 小胖子罗军来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：中药单体
经验分享：不收植物提取小分子的文章了，让改投到子刊

0 0

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2024-01-27 P拾荒者来自浙江省

偏重的研究方向：肿瘤
经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况

23 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2024-01-03 1225de92m39暂无昵称来自广东省

请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？

16 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2023-11-01 ms1000000150741111 来自上海

10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？

31 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2023-06-03 1473ac4am82暂无昵称来自四川省

偏重的研究方向：肿瘤
经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命

49 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2024-02-28 不死鸟的飞翔来自重庆

偏重的研究方向：肿瘤
经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收

18 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2023-11-07 ms7000001072468055 来自北京

请问综述的checklist有模板吗？

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审15天，一周修回，2小时后accept，效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审20天，给了一个月修回，修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：不收植物提取小分子的文章了，让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=6小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向：肿瘤 经验分享：邀请了8个审稿人，一周了没人接受审稿，哎，啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules，若我文章不属于这两项内容，这两个框框还需要进行勾选吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交，当天过了大约两小时就with editor了，然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢？有小伙伴有过类似的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向：肿瘤 经验分享：综述，周五晚上9点提交的，周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向：肿瘤 经验分享：刚接收了1篇，审稿1个月，给了2个月修改的时间，周末修回，3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156521, encodeId=0289215652162, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：单体;中药;综述 经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45226154506, createdName=ms7000000804202809, createdTime=Thu Sep 07 11:07:06 CST 2023, time=2023-09-07, status=1, ipAttribution=四川省)]

2023-09-07 ms7000000804202809 来自四川省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：单体;中药;综述
经验分享：投稿审完，Decision in Process已经两个月了还没返回意见，这正常吗

0 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务